TY - JOUR TI - Double-strand break DNA repair genotype predictive of later mortality and cancer incidence in a cohort of non-smokers AU - Neasham, D. AU - Gallo, V. AU - Guarrera, S. AU - Dunning, A. AU - Overvad, K. AU - Tjonneland, A. AU - Clavel-Chapelon, F. AU - Linseisen, J.P. AU - Malaveille, C. AU - Ferrari, P. AU - Boeing, H. AU - Benetou, V. AU - Trichopoulou, A. AU - Palli, D. AU - Crosignani, P. AU - Tumino, R. AU - Panico, S. AU - Bueno-De-Mesquita, H.B. AU - Peeters, P.H. AU - van Gib, C.H. AU - Lund, E. AU - Gonzalez, C.A. AU - Martinez, C. AU - Dorronsoro, M. AU - Barricarte, A. AU - Navarro, C. AU - Quiros, J.R. AU - Berglund, G. AU - Jarvholm, B. AU - Khaw, K.T. AU - Key, T.J. AU - Bingham, S. AU - Diaz, T.M.J. AU - Riboli, E. AU - Matullo, G. AU - Vineis, P. JO - DNA Repair PY - 2009 VL - 8 TODO - 1 SP - 60-71 PB - SN - 1568-7864 TODO - 10.1016/j.dnarep.2008.08.012 TODO - adult; aged; allelism; article; cancer incidence; cancer mortality; cohort analysis; DNA repair; DNA strand breakage; excision repair; female; genetic association; genetic polymorphism; genetic risk; genetic variability; genotype; human; human tissue; major clinical study; male; priority journal; prospective study; risk assessment, Cohort Studies; DNA Breaks, Double-Stranded; DNA Repair; Genetic Predisposition to Disease; Genotype; Humans; Incidence; Mortality; Neoplasms; Polymorphism, Genetic; Prospective Studies; Risk Factors TODO - We followed-up for mortality and cancer incidence 1088 healthy non-smokers from a population-based study, who were characterized for 22 variants in 16 genes involved in DNA repair pathways. Follow-up was 100% complete. The association between polymorphism and mortality or cancer incidence was analyzed using Cox Proportional Hazard regression models. Ninety-five subjects had died in a median follow-up time of 78 months (inter-quartile range 59-93 months). None of the genotypes was clearly associated with total mortality, except variants for two Double-Strand Break DNA repair genes, XRCC3 18067 C > T (rs#861539) and XRCC2 31479 G > A (rs#3218536). Adjusted hazard ratios were 2.25 (1.32-3.83) for the XRCC3 C/T genotype and 2.04 (1.00-4.13) for the T/T genotype (reference C/C), and 2.12 (1.14-3.97) for the XRCC2 G/A genotype (reference G/G). For total cancer mortality, the adjusted hazard ratios were 3.29 (1.23-7.82) for XRCC3 C/T, 2.84 (0.81-9.90) for XRCC3 T/T and 3.17 (1.21-8.30) for XRCC2 G/A. With combinations of three or more adverse alleles, the adjusted hazard ratio for all cause mortality was 17.29 (95% C.I. 8.13-36.74), and for all incident cancers the HR was 5.28 (95% C.I. 2.17-12.85). Observations from this prospective study suggest that polymorphisms of genes involved in the repair of DNA double-strand breaks significantly influence the risk of cancer and non-cancer disease, and can influence mortality. © 2008 Elsevier B.V. All rights reserved. ER -